These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Calcium-induced dissociation of CIB1 from ASK1 regulates agonist-induced activation of the p38 MAPK pathway in platelets. Patel P; Naik MU; Golla K; Shaik NF; Naik UP Biochem J; 2019 Oct; 476(19):2835-2850. PubMed ID: 31530712 [TBL] [Abstract][Full Text] [Related]
4. P2Y12 receptor-mediated potentiation of thrombin-induced thromboxane A2 generation in platelets occurs through regulation of Erk1/2 activation. Shankar H; Garcia A; Prabhakar J; Kim S; Kunapuli SP J Thromb Haemost; 2006 Mar; 4(3):638-47. PubMed ID: 16460446 [TBL] [Abstract][Full Text] [Related]
5. Skepinone-L, a novel potent and highly selective inhibitor of p38 MAP kinase, effectively impairs platelet activation and thrombus formation. Borst O; Walker B; Münzer P; Russo A; Schmid E; Faggio C; Bigalke B; Laufer S; Gawaz M; Lang F Cell Physiol Biochem; 2013; 31(6):914-24. PubMed ID: 23817201 [TBL] [Abstract][Full Text] [Related]
6. A role for p38 MAP kinase in platelet activation by von Willebrand factor. Canobbio I; Reineri S; Sinigaglia F; Balduini C; Torti M Thromb Haemost; 2004 Jan; 91(1):102-10. PubMed ID: 14691575 [TBL] [Abstract][Full Text] [Related]
7. Phosphorylation and activation of cytosolic phospholipase A2 by 38-kDa mitogen-activated protein kinase in collagen-stimulated human platelets. Börsch-Haubold AG; Kramer RM; Watson SP Eur J Biochem; 1997 May; 245(3):751-9. PubMed ID: 9183015 [TBL] [Abstract][Full Text] [Related]
8. Phosphoinositide 3-kinase p110α negatively regulates thrombopoietin-mediated platelet activation and thrombus formation. Blair TA; Moore SF; Walsh TG; Hutchinson JL; Durrant TN; Anderson KE; Poole AW; Hers I Cell Signal; 2018 Oct; 50():111-120. PubMed ID: 29793021 [TBL] [Abstract][Full Text] [Related]
9. P2X1-initiated p38 signalling enhances thromboxane A2-induced platelet secretion and aggregation. Huang Z; Liu P; Zhu L; Li N; Hu H Thromb Haemost; 2014 Jul; 112(1):142-50. PubMed ID: 24633352 [TBL] [Abstract][Full Text] [Related]
10. Src family kinase-mediated and Erk-mediated thromboxane A2 generation are essential for VWF/GPIb-induced fibrinogen receptor activation in human platelets. Garcia A; Quinton TM; Dorsam RT; Kunapuli SP Blood; 2005 Nov; 106(10):3410-4. PubMed ID: 16020504 [TBL] [Abstract][Full Text] [Related]
11. Evidence for a role for phospholipase C, but not phospholipase A2, in platelet activation in response to low concentrations of collagen. Lockhart LK; Pampolina C; Nickolaychuk BR; McNicol A Thromb Haemost; 2001 May; 85(5):882-9. PubMed ID: 11372683 [TBL] [Abstract][Full Text] [Related]
12. Antiplatelet effect of catechol is related to inhibition of cyclooxygenase, reactive oxygen species, ERK/p38 signaling and thromboxane A2 production. Chang MC; Chang HH; Wang TM; Chan CP; Lin BR; Yeung SY; Yeh CY; Cheng RH; Jeng JH PLoS One; 2014; 9(8):e104310. PubMed ID: 25122505 [TBL] [Abstract][Full Text] [Related]
13. Thrombin stimulation of p38 MAP kinase in human platelets is mediated by ADP and thromboxane A2 and inhibited by cGMP/cGMP-dependent protein kinase. Begonja AJ; Geiger J; Rukoyatkina N; Rauchfuss S; Gambaryan S; Walter U Blood; 2007 Jan; 109(2):616-8. PubMed ID: 16990590 [TBL] [Abstract][Full Text] [Related]
14. Amyloid beta peptide-activated signal pathways in human platelets. Shen MY; Hsiao G; Fong TH; Chen HM; Chou DS; Lin CH; Sheu JR; Hsu CY Eur J Pharmacol; 2008 Jul; 588(2-3):259-66. PubMed ID: 18511035 [TBL] [Abstract][Full Text] [Related]
15. Effect of selective inhibition of the p38 MAP kinase pathway on platelet aggregation. Kuliopulos A; Mohanlal R; Covic L Thromb Haemost; 2004 Dec; 92(6):1387-93. PubMed ID: 15583748 [TBL] [Abstract][Full Text] [Related]
16. Functional role of p38 mitogen activated protein kinase in platelet activation induced by a thromboxane A2 analogue and by 8-iso-prostaglandin F2alpha. Minuz P; Gaino S; Zuliani V; Tommasoli RM; Benati D; Ortolani R; Zancanaro C; Berton G; Santonastaso CL Thromb Haemost; 2002 May; 87(5):888-98. PubMed ID: 12038794 [TBL] [Abstract][Full Text] [Related]
17. PDK1 governs thromboxane generation and thrombosis in platelets by regulating activation of Raf1 in the MAPK pathway. Manne BK; Münzer P; Badolia R; Walker-Allgaier B; Campbell RA; Middleton E; Weyrich AS; Kunapuli SP; Borst O; Rondina MT J Thromb Haemost; 2018 Jun; 16(6):1211-1225. PubMed ID: 29575487 [TBL] [Abstract][Full Text] [Related]
19. RIP1-mediated AIP1 phosphorylation at a 14-3-3-binding site is critical for tumor necrosis factor-induced ASK1-JNK/p38 activation. Zhang H; Zhang H; Lin Y; Li J; Pober JS; Min W J Biol Chem; 2007 May; 282(20):14788-96. PubMed ID: 17389591 [TBL] [Abstract][Full Text] [Related]
20. Anisomycin does not activate p38MAPK in human platelets. Pampolina C; McNicol A Thromb Res; 1999 Oct; 96(1):27-35. PubMed ID: 10554082 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]